POLB — Poolbeg Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- £14.50m
- £4.44m
Annual cashflow statement for Poolbeg Pharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -2.34 | -4.78 | -4.5 |
| Amortisation | |||
| Non-Cash Items | 0.24 | 0.22 | -0.131 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -0.068 | 0.163 | 0.229 |
| Change in Accounts Receivable | |||
| Change in Payable / Accrued Expenses | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -2.15 | -4.37 | -4.38 |
| Capital Expenditures | -0.081 | -0.597 | -0.175 |
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | — | 0.209 | 0.534 |
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -0.081 | -0.388 | 0.359 |
| Financing Cash Flow Items | — | — | 0 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 23.2 | 0 | 0 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 20.9 | -4.76 | -4.02 |